Global Equine Chorionic Gonadotropin (eCG) Market Growth 2026-2032
The global Equine Chorionic Gonadotropin (eCG) market size is predicted to grow from US$ 276 million in 2025 to US$ 385 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.
In 2024, global Equine Chorionic Gonadotropin production reached approximately 31.47 million units, with an average global market price of around US$8.5 per unit. Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
Equine Chorionic Gonadotropin (eCG) is a highly active biological hormone widely used in animal reproduction management and livestock production. With the modernization and intensification of global livestock farming, there is increasing demand to improve reproductive efficiency and overall productivity, which has steadily expanded the eCG market. In addition, the growing adoption of research techniques and in vitro fertilization has further promoted the application of eCG in scientific studies and assisted reproductive technologies. In the future, improvements in manufacturing processes and quality control are expected to enhance the stability and safety of eCG products, providing more efficient reproductive management tools for the livestock industry. Moreover, trends such as animal welfare, sustainable farming practices, and biotechnological innovations are likely to drive the development of eCG toward higher purity, greater biological activity, and customized formulations, creating new market opportunities. Overall, the eCG market demonstrates strong growth potential, with expanding application areas and significant room for technological advancement. Its role in optimizing animal reproduction and supporting modern farming practices ensures continued relevance and demand in the evolving livestock industry.
LP Information, Inc. (LPI) ' newest research report, the ?Equine Chorionic Gonadotropin (eCG) Industry Forecast? looks at past sales and reviews total world Equine Chorionic Gonadotropin (eCG) sales in 2025, providing a comprehensive analysis by region and market sector of projected Equine Chorionic Gonadotropin (eCG) sales for 2026 through 2032. With Equine Chorionic Gonadotropin (eCG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Chorionic Gonadotropin (eCG) industry.
This Insight Report provides a comprehensive analysis of the global Equine Chorionic Gonadotropin (eCG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Chorionic Gonadotropin (eCG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Equine Chorionic Gonadotropin (eCG) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Chorionic Gonadotropin (eCG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Chorionic Gonadotropin (eCG).
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Chorionic Gonadotropin (eCG) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2024, global Equine Chorionic Gonadotropin production reached approximately 31.47 million units, with an average global market price of around US$8.5 per unit. Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
Equine Chorionic Gonadotropin (eCG) is a highly active biological hormone widely used in animal reproduction management and livestock production. With the modernization and intensification of global livestock farming, there is increasing demand to improve reproductive efficiency and overall productivity, which has steadily expanded the eCG market. In addition, the growing adoption of research techniques and in vitro fertilization has further promoted the application of eCG in scientific studies and assisted reproductive technologies. In the future, improvements in manufacturing processes and quality control are expected to enhance the stability and safety of eCG products, providing more efficient reproductive management tools for the livestock industry. Moreover, trends such as animal welfare, sustainable farming practices, and biotechnological innovations are likely to drive the development of eCG toward higher purity, greater biological activity, and customized formulations, creating new market opportunities. Overall, the eCG market demonstrates strong growth potential, with expanding application areas and significant room for technological advancement. Its role in optimizing animal reproduction and supporting modern farming practices ensures continued relevance and demand in the evolving livestock industry.
LP Information, Inc. (LPI) ' newest research report, the ?Equine Chorionic Gonadotropin (eCG) Industry Forecast? looks at past sales and reviews total world Equine Chorionic Gonadotropin (eCG) sales in 2025, providing a comprehensive analysis by region and market sector of projected Equine Chorionic Gonadotropin (eCG) sales for 2026 through 2032. With Equine Chorionic Gonadotropin (eCG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Chorionic Gonadotropin (eCG) industry.
This Insight Report provides a comprehensive analysis of the global Equine Chorionic Gonadotropin (eCG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Chorionic Gonadotropin (eCG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Equine Chorionic Gonadotropin (eCG) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Chorionic Gonadotropin (eCG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Chorionic Gonadotropin (eCG).
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Chorionic Gonadotropin (eCG) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1000IU/Units
- 5000IU/Units
- Others
- Pigs
- Cattles
- Sheeps
- Horses
- Other Animals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MSD Animal Health
- Ceva Sant? Animale
- Syntex SA
- Bioveta
- Ningbo Sansheng Biological Technology
- Ningbo Second Hormone Factory
- Chifeng Bo-en Pharmaceutical
- Guangzhou Vbio-Pharma
- JALLY
- Ningbo Creator Animal Pharmaceutical
- What is the 10-year outlook for the global Equine Chorionic Gonadotropin (eCG) market?
- What factors are driving Equine Chorionic Gonadotropin (eCG) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Equine Chorionic Gonadotropin (eCG) market opportunities vary by end market size?
- How does Equine Chorionic Gonadotropin (eCG) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) by Country/Region, 2021, 2025 & 2032
2.2 Equine Chorionic Gonadotropin (eCG) Segment by Type
2.2.1 1000IU/Units
2.2.2 5000IU/Units
2.2.3 Others
2.2.4 Equine Chorionic Gonadotropin (eCG) Sales by Type
2.2.4.1 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
2.2.4.2 Global Equine Chorionic Gonadotropin (eCG) Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Type (2021-2026)
2.3 Equine Chorionic Gonadotropin (eCG) Segment by Application
2.3.1 Pigs
2.3.2 Cattles
2.3.3 Sheeps
2.3.4 Horses
2.3.5 Other Animals
2.3.6 Equine Chorionic Gonadotropin (eCG) Sales by Application
2.3.6.1 Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2021-2026)
2.3.6.2 Global Equine Chorionic Gonadotropin (eCG) Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Equine Chorionic Gonadotropin (eCG) Breakdown Data by Company
3.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Company (2021-2026)
3.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company (2021-2026)
3.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Company (2021-2026)
3.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Company (2021-2026)
3.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company (2021-2026)
3.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Company
3.4 Key Manufacturers Equine Chorionic Gonadotropin (eCG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Chorionic Gonadotropin (eCG) Product Location Distribution
3.4.2 Players Equine Chorionic Gonadotropin (eCG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) BY GEOGRAPHIC REGION
4.1 World Historic Equine Chorionic Gonadotropin (eCG) Market Size by Geographic Region (2021-2026)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Equine Chorionic Gonadotropin (eCG) Market Size by Country/Region (2021-2026)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Equine Chorionic Gonadotropin (eCG) Sales Growth
4.4 APAC Equine Chorionic Gonadotropin (eCG) Sales Growth
4.5 Europe Equine Chorionic Gonadotropin (eCG) Sales Growth
4.6 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Growth
5 AMERICAS
5.1 Americas Equine Chorionic Gonadotropin (eCG) Sales by Country
5.1.1 Americas Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
5.1.2 Americas Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
5.2 Americas Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
5.3 Americas Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Chorionic Gonadotropin (eCG) Sales by Region
6.1.1 APAC Equine Chorionic Gonadotropin (eCG) Sales by Region (2021-2026)
6.1.2 APAC Equine Chorionic Gonadotropin (eCG) Revenue by Region (2021-2026)
6.2 APAC Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
6.3 APAC Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Chorionic Gonadotropin (eCG) by Country
7.1.1 Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
7.1.2 Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
7.2 Europe Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
7.3 Europe Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) by Country
8.1.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
8.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
8.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG)
10.3 Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
10.4 Industry Chain Structure of Equine Chorionic Gonadotropin (eCG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Chorionic Gonadotropin (eCG) Distributors
11.3 Equine Chorionic Gonadotropin (eCG) Customer
12 WORLD FORECAST REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) BY GEOGRAPHIC REGION
12.1 Global Equine Chorionic Gonadotropin (eCG) Market Size Forecast by Region
12.1.1 Global Equine Chorionic Gonadotropin (eCG) Forecast by Region (2027-2032)
12.1.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Equine Chorionic Gonadotropin (eCG) Forecast by Type (2027-2032)
12.7 Global Equine Chorionic Gonadotropin (eCG) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Syntex SA
13.3.1 Syntex SA Company Information
13.3.2 Syntex SA Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Syntex SA Main Business Overview
13.3.5 Syntex SA Latest Developments
13.4 Bioveta
13.4.1 Bioveta Company Information
13.4.2 Bioveta Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bioveta Main Business Overview
13.4.5 Bioveta Latest Developments
13.5 Ningbo Sansheng Biological Technology
13.5.1 Ningbo Sansheng Biological Technology Company Information
13.5.2 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ningbo Sansheng Biological Technology Main Business Overview
13.5.5 Ningbo Sansheng Biological Technology Latest Developments
13.6 Ningbo Second Hormone Factory
13.6.1 Ningbo Second Hormone Factory Company Information
13.6.2 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ningbo Second Hormone Factory Main Business Overview
13.6.5 Ningbo Second Hormone Factory Latest Developments
13.7 Chifeng Bo-en Pharmaceutical
13.7.1 Chifeng Bo-en Pharmaceutical Company Information
13.7.2 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Chifeng Bo-en Pharmaceutical Main Business Overview
13.7.5 Chifeng Bo-en Pharmaceutical Latest Developments
13.8 Guangzhou Vbio-Pharma
13.8.1 Guangzhou Vbio-Pharma Company Information
13.8.2 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou Vbio-Pharma Main Business Overview
13.8.5 Guangzhou Vbio-Pharma Latest Developments
13.9 JALLY
13.9.1 JALLY Company Information
13.9.2 JALLY Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.9.3 JALLY Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 JALLY Main Business Overview
13.9.5 JALLY Latest Developments
13.10 Ningbo Creator Animal Pharmaceutical
13.10.1 Ningbo Creator Animal Pharmaceutical Company Information
13.10.2 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ningbo Creator Animal Pharmaceutical Main Business Overview
13.10.5 Ningbo Creator Animal Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) by Country/Region, 2021, 2025 & 2032
2.2 Equine Chorionic Gonadotropin (eCG) Segment by Type
2.2.1 1000IU/Units
2.2.2 5000IU/Units
2.2.3 Others
2.2.4 Equine Chorionic Gonadotropin (eCG) Sales by Type
2.2.4.1 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
2.2.4.2 Global Equine Chorionic Gonadotropin (eCG) Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Type (2021-2026)
2.3 Equine Chorionic Gonadotropin (eCG) Segment by Application
2.3.1 Pigs
2.3.2 Cattles
2.3.3 Sheeps
2.3.4 Horses
2.3.5 Other Animals
2.3.6 Equine Chorionic Gonadotropin (eCG) Sales by Application
2.3.6.1 Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2021-2026)
2.3.6.2 Global Equine Chorionic Gonadotropin (eCG) Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Equine Chorionic Gonadotropin (eCG) Breakdown Data by Company
3.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Company (2021-2026)
3.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company (2021-2026)
3.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Company (2021-2026)
3.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Company (2021-2026)
3.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company (2021-2026)
3.3 Global Equine Chorionic Gonadotropin (eCG) Sale Price by Company
3.4 Key Manufacturers Equine Chorionic Gonadotropin (eCG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Chorionic Gonadotropin (eCG) Product Location Distribution
3.4.2 Players Equine Chorionic Gonadotropin (eCG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) BY GEOGRAPHIC REGION
4.1 World Historic Equine Chorionic Gonadotropin (eCG) Market Size by Geographic Region (2021-2026)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Equine Chorionic Gonadotropin (eCG) Market Size by Country/Region (2021-2026)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Equine Chorionic Gonadotropin (eCG) Sales Growth
4.4 APAC Equine Chorionic Gonadotropin (eCG) Sales Growth
4.5 Europe Equine Chorionic Gonadotropin (eCG) Sales Growth
4.6 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Growth
5 AMERICAS
5.1 Americas Equine Chorionic Gonadotropin (eCG) Sales by Country
5.1.1 Americas Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
5.1.2 Americas Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
5.2 Americas Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
5.3 Americas Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Chorionic Gonadotropin (eCG) Sales by Region
6.1.1 APAC Equine Chorionic Gonadotropin (eCG) Sales by Region (2021-2026)
6.1.2 APAC Equine Chorionic Gonadotropin (eCG) Revenue by Region (2021-2026)
6.2 APAC Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
6.3 APAC Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Chorionic Gonadotropin (eCG) by Country
7.1.1 Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
7.1.2 Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
7.2 Europe Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
7.3 Europe Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) by Country
8.1.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026)
8.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026)
8.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG)
10.3 Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
10.4 Industry Chain Structure of Equine Chorionic Gonadotropin (eCG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Chorionic Gonadotropin (eCG) Distributors
11.3 Equine Chorionic Gonadotropin (eCG) Customer
12 WORLD FORECAST REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) BY GEOGRAPHIC REGION
12.1 Global Equine Chorionic Gonadotropin (eCG) Market Size Forecast by Region
12.1.1 Global Equine Chorionic Gonadotropin (eCG) Forecast by Region (2027-2032)
12.1.2 Global Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Equine Chorionic Gonadotropin (eCG) Forecast by Type (2027-2032)
12.7 Global Equine Chorionic Gonadotropin (eCG) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Syntex SA
13.3.1 Syntex SA Company Information
13.3.2 Syntex SA Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Syntex SA Main Business Overview
13.3.5 Syntex SA Latest Developments
13.4 Bioveta
13.4.1 Bioveta Company Information
13.4.2 Bioveta Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bioveta Main Business Overview
13.4.5 Bioveta Latest Developments
13.5 Ningbo Sansheng Biological Technology
13.5.1 Ningbo Sansheng Biological Technology Company Information
13.5.2 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ningbo Sansheng Biological Technology Main Business Overview
13.5.5 Ningbo Sansheng Biological Technology Latest Developments
13.6 Ningbo Second Hormone Factory
13.6.1 Ningbo Second Hormone Factory Company Information
13.6.2 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ningbo Second Hormone Factory Main Business Overview
13.6.5 Ningbo Second Hormone Factory Latest Developments
13.7 Chifeng Bo-en Pharmaceutical
13.7.1 Chifeng Bo-en Pharmaceutical Company Information
13.7.2 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Chifeng Bo-en Pharmaceutical Main Business Overview
13.7.5 Chifeng Bo-en Pharmaceutical Latest Developments
13.8 Guangzhou Vbio-Pharma
13.8.1 Guangzhou Vbio-Pharma Company Information
13.8.2 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou Vbio-Pharma Main Business Overview
13.8.5 Guangzhou Vbio-Pharma Latest Developments
13.9 JALLY
13.9.1 JALLY Company Information
13.9.2 JALLY Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.9.3 JALLY Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 JALLY Main Business Overview
13.9.5 JALLY Latest Developments
13.10 Ningbo Creator Animal Pharmaceutical
13.10.1 Ningbo Creator Animal Pharmaceutical Company Information
13.10.2 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
13.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ningbo Creator Animal Pharmaceutical Main Business Overview
13.10.5 Ningbo Creator Animal Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Chorionic Gonadotropin (eCG) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Equine Chorionic Gonadotropin (eCG) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1000IU/Units
Table 4. Major Players of 5000IU/Units
Table 5. Major Players of Others
Table 6. Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 7. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Table 8. Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2021-2026) & ($ million)
Table 9. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2021-2026)
Table 10. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Equine Chorionic Gonadotropin (eCG) Sale by Application (2021-2026) & (K Units)
Table 12. Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2021-2026)
Table 13. Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2021-2026) & ($ million)
Table 14. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2021-2026)
Table 15. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Equine Chorionic Gonadotropin (eCG) Sales by Company (2021-2026) & (K Units)
Table 17. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company (2021-2026)
Table 18. Global Equine Chorionic Gonadotropin (eCG) Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company (2021-2026)
Table 20. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Equine Chorionic Gonadotropin (eCG) Producing Area Distribution and Sales Area
Table 22. Players Equine Chorionic Gonadotropin (eCG) Products Offered
Table 23. Equine Chorionic Gonadotropin (eCG) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Equine Chorionic Gonadotropin (eCG) Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Geographic Region (2021-2026)
Table 28. Global Equine Chorionic Gonadotropin (eCG) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Equine Chorionic Gonadotropin (eCG) Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2021-2026)
Table 32. Global Equine Chorionic Gonadotropin (eCG) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 35. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2021-2026)
Table 36. Americas Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 38. Americas Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 39. APAC Equine Chorionic Gonadotropin (eCG) Sales by Region (2021-2026) & (K Units)
Table 40. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2021-2026)
Table 41. APAC Equine Chorionic Gonadotropin (eCG) Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 43. APAC Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 44. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 45. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 47. Europe Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Equine Chorionic Gonadotropin (eCG)
Table 53. Key Market Challenges & Risks of Equine Chorionic Gonadotropin (eCG)
Table 54. Key Industry Trends of Equine Chorionic Gonadotropin (eCG)
Table 55. Equine Chorionic Gonadotropin (eCG) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Equine Chorionic Gonadotropin (eCG) Distributors List
Table 58. Equine Chorionic Gonadotropin (eCG) Customer List
Table 59. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Equine Chorionic Gonadotropin (eCG) Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. MSD Animal Health Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 75. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. MSD Animal Health Main Business
Table 77. MSD Animal Health Latest Developments
Table 78. Ceva Sant? Animale Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 79. Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 80. Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Ceva Sant? Animale Main Business
Table 82. Ceva Sant? Animale Latest Developments
Table 83. Syntex SA Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 84. Syntex SA Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 85. Syntex SA Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Syntex SA Main Business
Table 87. Syntex SA Latest Developments
Table 88. Bioveta Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 89. Bioveta Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 90. Bioveta Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Bioveta Main Business
Table 92. Bioveta Latest Developments
Table 93. Ningbo Sansheng Biological Technology Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 94. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 95. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Ningbo Sansheng Biological Technology Main Business
Table 97. Ningbo Sansheng Biological Technology Latest Developments
Table 98. Ningbo Second Hormone Factory Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 99. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 100. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Ningbo Second Hormone Factory Main Business
Table 102. Ningbo Second Hormone Factory Latest Developments
Table 103. Chifeng Bo-en Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 104. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 105. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Chifeng Bo-en Pharmaceutical Main Business
Table 107. Chifeng Bo-en Pharmaceutical Latest Developments
Table 108. Guangzhou Vbio-Pharma Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 110. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guangzhou Vbio-Pharma Main Business
Table 112. Guangzhou Vbio-Pharma Latest Developments
Table 113. JALLY Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 114. JALLY Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 115. JALLY Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. JALLY Main Business
Table 117. JALLY Latest Developments
Table 118. Ningbo Creator Animal Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 119. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 120. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Ningbo Creator Animal Pharmaceutical Main Business
Table 122. Ningbo Creator Animal Pharmaceutical Latest Developments
Table 1. Equine Chorionic Gonadotropin (eCG) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Equine Chorionic Gonadotropin (eCG) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1000IU/Units
Table 4. Major Players of 5000IU/Units
Table 5. Major Players of Others
Table 6. Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 7. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Table 8. Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2021-2026) & ($ million)
Table 9. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2021-2026)
Table 10. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Equine Chorionic Gonadotropin (eCG) Sale by Application (2021-2026) & (K Units)
Table 12. Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2021-2026)
Table 13. Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2021-2026) & ($ million)
Table 14. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2021-2026)
Table 15. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Equine Chorionic Gonadotropin (eCG) Sales by Company (2021-2026) & (K Units)
Table 17. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company (2021-2026)
Table 18. Global Equine Chorionic Gonadotropin (eCG) Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company (2021-2026)
Table 20. Global Equine Chorionic Gonadotropin (eCG) Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Equine Chorionic Gonadotropin (eCG) Producing Area Distribution and Sales Area
Table 22. Players Equine Chorionic Gonadotropin (eCG) Products Offered
Table 23. Equine Chorionic Gonadotropin (eCG) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Equine Chorionic Gonadotropin (eCG) Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Geographic Region (2021-2026)
Table 28. Global Equine Chorionic Gonadotropin (eCG) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Equine Chorionic Gonadotropin (eCG) Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2021-2026)
Table 32. Global Equine Chorionic Gonadotropin (eCG) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 35. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2021-2026)
Table 36. Americas Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 38. Americas Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 39. APAC Equine Chorionic Gonadotropin (eCG) Sales by Region (2021-2026) & (K Units)
Table 40. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2021-2026)
Table 41. APAC Equine Chorionic Gonadotropin (eCG) Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 43. APAC Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 44. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 45. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 47. Europe Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Equine Chorionic Gonadotropin (eCG)
Table 53. Key Market Challenges & Risks of Equine Chorionic Gonadotropin (eCG)
Table 54. Key Industry Trends of Equine Chorionic Gonadotropin (eCG)
Table 55. Equine Chorionic Gonadotropin (eCG) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Equine Chorionic Gonadotropin (eCG) Distributors List
Table 58. Equine Chorionic Gonadotropin (eCG) Customer List
Table 59. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Equine Chorionic Gonadotropin (eCG) Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Equine Chorionic Gonadotropin (eCG) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Equine Chorionic Gonadotropin (eCG) Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Equine Chorionic Gonadotropin (eCG) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. MSD Animal Health Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 75. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. MSD Animal Health Main Business
Table 77. MSD Animal Health Latest Developments
Table 78. Ceva Sant? Animale Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 79. Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 80. Ceva Sant? Animale Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Ceva Sant? Animale Main Business
Table 82. Ceva Sant? Animale Latest Developments
Table 83. Syntex SA Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 84. Syntex SA Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 85. Syntex SA Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Syntex SA Main Business
Table 87. Syntex SA Latest Developments
Table 88. Bioveta Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 89. Bioveta Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 90. Bioveta Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Bioveta Main Business
Table 92. Bioveta Latest Developments
Table 93. Ningbo Sansheng Biological Technology Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 94. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 95. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Ningbo Sansheng Biological Technology Main Business
Table 97. Ningbo Sansheng Biological Technology Latest Developments
Table 98. Ningbo Second Hormone Factory Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 99. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 100. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Ningbo Second Hormone Factory Main Business
Table 102. Ningbo Second Hormone Factory Latest Developments
Table 103. Chifeng Bo-en Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 104. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 105. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Chifeng Bo-en Pharmaceutical Main Business
Table 107. Chifeng Bo-en Pharmaceutical Latest Developments
Table 108. Guangzhou Vbio-Pharma Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 110. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guangzhou Vbio-Pharma Main Business
Table 112. Guangzhou Vbio-Pharma Latest Developments
Table 113. JALLY Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 114. JALLY Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 115. JALLY Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. JALLY Main Business
Table 117. JALLY Latest Developments
Table 118. Ningbo Creator Animal Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) Manufacturing Base, Sales Area and Its Competitors
Table 119. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Product Portfolios and Specifications
Table 120. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Ningbo Creator Animal Pharmaceutical Main Business
Table 122. Ningbo Creator Animal Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Chorionic Gonadotropin (eCG)
Figure 2. Equine Chorionic Gonadotropin (eCG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Chorionic Gonadotropin (eCG) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Equine Chorionic Gonadotropin (eCG) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2025)
Figure 10. Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1000IU/Units
Figure 12. Product Picture of 5000IU/Units
Figure 13. Product Picture of Others
Figure 14. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type in 2026
Figure 15. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2021-2026)
Figure 16. Equine Chorionic Gonadotropin (eCG) Consumed in Pigs
Figure 17. Global Equine Chorionic Gonadotropin (eCG) Market: Pigs (2021-2026) & (K Units)
Figure 18. Equine Chorionic Gonadotropin (eCG) Consumed in Cattles
Figure 19. Global Equine Chorionic Gonadotropin (eCG) Market: Cattles (2021-2026) & (K Units)
Figure 20. Equine Chorionic Gonadotropin (eCG) Consumed in Sheeps
Figure 21. Global Equine Chorionic Gonadotropin (eCG) Market: Sheeps (2021-2026) & (K Units)
Figure 22. Equine Chorionic Gonadotropin (eCG) Consumed in Horses
Figure 23. Global Equine Chorionic Gonadotropin (eCG) Market: Horses (2021-2026) & (K Units)
Figure 24. Equine Chorionic Gonadotropin (eCG) Consumed in Other Animals
Figure 25. Global Equine Chorionic Gonadotropin (eCG) Market: Other Animals (2021-2026) & (K Units)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2025)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application in 2026
Figure 28. Equine Chorionic Gonadotropin (eCG) Sales by Company in 2026 (K Units)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company in 2026
Figure 30. Equine Chorionic Gonadotropin (eCG) Revenue by Company in 2026 ($ millions)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company in 2026
Figure 32. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 35. Americas Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 36. APAC Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 37. APAC Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 38. Europe Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 42. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country in 2026
Figure 43. Americas Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Figure 44. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 45. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 46. United States Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region in 2026
Figure 51. APAC Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2021-2026)
Figure 52. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 53. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 54. China Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 58. India Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country in 2026
Figure 62. Europe Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Figure 63. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 64. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 65. Germany Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 66. France Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 73. Egypt Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) in 2026
Figure 79. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
Figure 80. Industry Chain Structure of Equine Chorionic Gonadotropin (eCG)
Figure 81. Channels of Distribution
Figure 82. Global Equine Chorionic Gonadotropin (eCG) Sales Market Forecast by Region (2027-2032)
Figure 83. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Equine Chorionic Gonadotropin (eCG)
Figure 2. Equine Chorionic Gonadotropin (eCG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Chorionic Gonadotropin (eCG) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Equine Chorionic Gonadotropin (eCG) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2025)
Figure 10. Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1000IU/Units
Figure 12. Product Picture of 5000IU/Units
Figure 13. Product Picture of Others
Figure 14. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type in 2026
Figure 15. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2021-2026)
Figure 16. Equine Chorionic Gonadotropin (eCG) Consumed in Pigs
Figure 17. Global Equine Chorionic Gonadotropin (eCG) Market: Pigs (2021-2026) & (K Units)
Figure 18. Equine Chorionic Gonadotropin (eCG) Consumed in Cattles
Figure 19. Global Equine Chorionic Gonadotropin (eCG) Market: Cattles (2021-2026) & (K Units)
Figure 20. Equine Chorionic Gonadotropin (eCG) Consumed in Sheeps
Figure 21. Global Equine Chorionic Gonadotropin (eCG) Market: Sheeps (2021-2026) & (K Units)
Figure 22. Equine Chorionic Gonadotropin (eCG) Consumed in Horses
Figure 23. Global Equine Chorionic Gonadotropin (eCG) Market: Horses (2021-2026) & (K Units)
Figure 24. Equine Chorionic Gonadotropin (eCG) Consumed in Other Animals
Figure 25. Global Equine Chorionic Gonadotropin (eCG) Market: Other Animals (2021-2026) & (K Units)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) Sale Market Share by Application (2025)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application in 2026
Figure 28. Equine Chorionic Gonadotropin (eCG) Sales by Company in 2026 (K Units)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Company in 2026
Figure 30. Equine Chorionic Gonadotropin (eCG) Revenue by Company in 2026 ($ millions)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Company in 2026
Figure 32. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 35. Americas Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 36. APAC Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 37. APAC Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 38. Europe Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue 2021-2026 ($ millions)
Figure 42. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country in 2026
Figure 43. Americas Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Figure 44. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 45. Americas Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 46. United States Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region in 2026
Figure 51. APAC Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2021-2026)
Figure 52. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 53. APAC Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 54. China Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 58. India Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country in 2026
Figure 62. Europe Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2021-2026)
Figure 63. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 64. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 65. Germany Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 66. France Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2021-2026)
Figure 73. Egypt Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Equine Chorionic Gonadotropin (eCG) Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) in 2026
Figure 79. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
Figure 80. Industry Chain Structure of Equine Chorionic Gonadotropin (eCG)
Figure 81. Channels of Distribution
Figure 82. Global Equine Chorionic Gonadotropin (eCG) Sales Market Forecast by Region (2027-2032)
Figure 83. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share Forecast by Application (2027-2032)
